| Name | RWJ 63556 |
|---|---|
| Synonyms |
Methanesulfonamide, N-[5-(4-fluorophenoxy)-2-thienyl]-
N-[5-(4-Fluorophenoxy)-2-thienyl]methanesulfonamide |
| Description | RWJ 63556 is an orally active COX-2 selective/5-lipoxygenase inhibitor, with anti-inflammatory activities. |
|---|---|
| Related Catalog | |
| Target |
COX-2 5-Lipoxygenase |
| In Vitro | RWJ 63556 is a potent inhibitor of leukocyte influx over a period of 24 hr and maintains its in vitro profile on eicosanoids[1]. |
| In Vivo | RWJ 63556 (1 mg/kg, i.v.) significantly inhibits the development of SP-induced oedema[2]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 403.4±55.0 °C at 760 mmHg |
| Molecular Formula | C11H10FNO3S2 |
| Molecular Weight | 287.330 |
| Flash Point | 197.8±31.5 °C |
| Exact Mass | 287.008606 |
| LogP | 4.22 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.624 |
| Storage condition | 2-8℃ |